Schlenk et al. [25] showed that in FLT3-ITD AML, an allelic ratio (AR) ≥0.51 at diagnosis was associated with an unfavorable relapse-free survival (RFS) and OS. This evidence concerns the gene FLT3 and acute myeloid leukemia.